Health
FDA Is Investigating If Sarepta’s Gene Therapy Should Stay on Market
FDA commissioner Martin Makary
Photographer: Annabelle Gordon/BloombergUS Food and Drug Administration Commissioner Marty Makary said he’s “taking a hard look” at whether a gene therapy from Sarepta Therapeutics Inc. should remain on the market.
Makary made the comments in an interview with Bloomberg News.